Evidence map›Paper›PMID 25743340›Full record

ArticleAmerican journal of ophthalmology2015

Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Ivaí, Brazil.

Claudio Silveira, Cristina Muccioli, Gary N Holland, Jeffrey L Jones, Fei Yu, Adam de Paulo, Rubens Belfort

Abstract read
PubMed Publisher
In one paragraph

Article in American journal of ophthalmology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Interferon-γ and IL-10 Release Assay for Patients with Ocular Toxoplasmosis.The American journal of tropical medicine and hygiene · 2020
    Article
  6. Article
  7. Evaluation of Serological and Molecular Tests Used for the Identification ofFrontiers in cellular and infection microbiology · 2019
    Article
  8. Public health risks associated with food-borne parasites.EFSA journal. European Food Safety Authority · 2018
    Article
  9. Review
  10. Review
  11. Symptomatic Acute Toxoplasmosis in Returning Travelers.Open forum infectious diseases · 2018
    Article
  12. Article
  13. Article
  14. Clustering of Toxoplasma gondii Infections Within Families of Congenitally Infected Infants.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2015
    Article
  15. Ocular toxoplasmosis: lessons from Brazil.American journal of ophthalmology · 2015
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors.

Claudio SilveiraDepartment of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil; Clínica Silveira, Erechim, Rio Grande do Sul, Brazil.
Cristina MuccioliDepartment of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
Gary N HollandOcular Inflammatory Disease Center, Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California. Electronic address: uveitis@jsei.ucla.edu.
Jeffrey L JonesDivision of Parasitic Diseases and Malaria, Center for Global Health, United States Centers for Disease Control and Prevention, Atlanta, Georgia.
Fei YuOcular Inflammatory Disease Center, Stein Eye Institute and the Department of Ophthalmology, David Geffen School of Medicine at UCLA, Los Angeles, California.
Adam de PauloDepartment of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.
Rubens BelfortDepartment of Ophthalmology, Federal University of São Paulo, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo investigate ocular involvement (prevalence, incidence, lesion characteristics) following postnatally acquired infection with an "atypical" genotype of Toxoplasma gondii during a well-characterized 2001 outbreak in Santa Isabel do Ivaí, Brazil, attributed to a contaminated municipal reservoir.

designProspective longitudinal cohort study.

methodsWe performed ophthalmic examinations on 290 of 454 individuals with serologic evidence of T gondii infection during the epidemic (positive IgM antibody tests). Prevalence of ophthalmic findings (intraocular inflammatory reactions [including transient, isolated retinal whitening without clinically apparent retinal necrosis] and necrotizing retinochoroiditis) at initial examination (baseline) and incidence of new findings during 10.5 months of follow-up were calculated. Cumulative risks of ophthalmic events were determined (Kaplan-Meier technique).

resultsOcular involvement was present in 33 of 288 IgM+ individuals (11.5%) at baseline, including 17 with focal retinal whitening only and 13 with necrotizing retinochoroiditis. Incidence of new ocular involvement was estimated to be 1.73 events per 100 person-months (PM); cumulative risk at 10.5 months was 30.1%. Incident necrotizing retinochoroiditis was more common among those with focal retinal whitening at baseline (6.7/100 PM) than among those with no ocular involvement at baseline (1.11/100 PM; hazard ratio 6.07 [1.94-19.01]; P < .0001).

conclusionsWaterborne infection with an atypical genotype of T gondii is associated with substantial risk of ocular involvement. Lesions may continue to develop during the first year after infection. The increased risk of late necrotizing retinochoroiditis associated with isolated focal retinal whitening at presentation suggests the early presence of parasites in the retina, despite initial lack of observable retinal necrosis.

Indexed as

Disease OutbreaksAdolescentAdultAgedAged, 80 and overAntibodies, ProtozoanAntiprotozoal AgentsBrazilChildChild, PreschoolChorioretinitisCohort StudiesEndemic DiseasesEnzyme-Linked Immunosorbent AssayFemaleFolic Acid AntagonistsAntibodies, ProtozoanAntiprotozoal AgentsFolic Acid AntagonistsImmunoglobulin MLeucovorinPyrimethamineSulfadiazineWater

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.